Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab

Journal of the Royal College of Physicians of Edinburgh

Volumn 41, Issue 3, 2011, Pages 215-217

  Cooksley, T ^a   Haji Michael, P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapeutic agents; Encephalopathy; Headache; PRES; Seizures

Indexed keywords

ALEMTUZUMAB; BENZODIAZEPINE DERIVATIVE; BICARBONATE; CREATININE; ELECTROLYTE; GANCICLOVIR; HEMOGLOBIN; LINEZOLID; MEROPENEM; METOPROLOL; PENTOSTATIN; PHENYTOIN; SEDATIVE AGENT; UREA; VORICONAZOLE; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; AGITATION; ARTERIAL GAS; BICARBONATE BLOOD LEVEL; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN EDEMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; EPILEPTIC STATE; FEVER; GRAND MAL SEIZURE; HEMOGLOBIN DETERMINATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; LEUKOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PROLYMPHOCYTIC LEUKEMIA; PULSE RATE; RESPIRATORY ACIDOSIS; RESTLESSNESS; REVIEW; SINUS TACHYCARDIA; THROMBOCYTE COUNT; UREA BLOOD LEVEL; CHEMICALLY INDUCED DISORDER;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; MALE; PENTOSTATIN; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84859403163     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2011.306     Document Type: Review

References (14)

1. Lee VH, Wijdicks EF, Manno EM et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65:205-210. doi:10.1001/archneurol.2007.46
2. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494-500. doi:10.1056/NEJM199602223340803
3. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77:24. doi:10.1136/pmj.77.903.24
4. Donmez FY, Basaran C, Kayahan Ulu EM et al. MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging 2010; 20:22-28. doi:10.1111/j.1552-6569.2008.00306.x
5. Ni J, Zhou LX, Hao H et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging 2010 Jun 21; epub ahead of print.
6. Fugate JE, Claassen DO, Cloft HJ et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85: 427-32. doi:10.4065/mcp.2009.0590
7. Kwon EJ, Kim SW, Kim KK et al. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat 2009; 41:53-55. doi:10.4143/crt.2009.41.1.53
8. Bürki F, Badie K, Bartoli P et al. Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/ doxorubicin regimen. Br J Clin Pharmacol 2008; 65:793-794. doi:10.1111/j.1365-2125.2008.03119.x
9. Rangi PS, Partridge WJ, Newlands ES et al. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anesthesia. Neuroradiology 2005; 47: 586-590. doi:10.1007/s00234-005-1376-6
10. Rajasekhar A, George TJ. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome. Oncologist 2007; 12:1332-35. doi:10.1634/theoncologist.12-11-1332
11. Hinchey JA. Reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65:175-76. doi:10.1001/archneurol.2007.62
12. Schwartz RB, Jones KM, Kalina P et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. Am J Roentgenol 1992; 159:379-383.
13. Hefzy HM, Bartynski WS, Boardman JF, et al. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. Am J Neuroradiol 2009; 30:1371-1379. doi:10.3174/ ajnr.A1588
14. Ay H, Buonanno FS, Schaefer PW et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion weighted MRI. Neurology 1998; 51:1369-1376.